Anduril Commands Up To 40% Premiums
Investors are paying up to a 40% premium for Anduril shares on secondary markets as Thrive Capital and Andreessen Horowitz prepare a reported $60 billion funding round. Data from Caplight and market platforms show buyer demand at 97% versus 3% sellers, while founders restrict sales and the company has not finalized the new round. The disparity highlights access and pricing tensions in private markets.
Key Points
- 1Showcases buyers paying up to 40% premiums for Anduril secondary shares amid a reported $60 billion valuation
- 2Highlights severe supply imbalance with 97% buyer demand versus 3% willing sellers on Caplight data
- 3Signals access divide: investors outside VC rounds must use secondaries and face scalping-like markups
Scoring Rationale
Uses cited market data and executive quotes, but focuses narrowly on one company and secondary-market dynamics.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems

